Overview

Terbinafine Treatment of Axial Spondyloarthropathy

Status:
Recruiting
Trial end date:
2024-10-15
Target enrollment:
Participant gender:
Summary
This is a pilot study to determine if further research is warranted to assess if anti-fungal therapy is an effective adjunctive treatment for axial spondyloarthropathy
Phase:
Early Phase 1
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
The Malassezia Foundation
Treatments:
Terbinafine